90378 Rsv mab intramuscular 50mg
Medicine
Also known as: RSV mAb, palivizumab, RSV prophylaxis
Respiratory syncytial virus monoclonal antibody administered intramuscularly in 50 milligram dose for prophylaxis.
Clinical Context
Monoclonal antibody prophylaxis for high-risk infants and young children, particularly those with congenital heart disease or chronic lung disease, to prevent respiratory syncytial virus disease.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.